查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1985051

2026年全球醫療微流體設備市場報告

Medical Microfluidic Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，醫用微流體控裝置市場規模快速擴張。預計該市場規模將從2025年的63.5億美元成長到2026年的73.2億美元，複合年成長率（CAGR）為15.3%。過去幾年成長要素包括：即時診斷技術的日益普及、晶片實驗室在研究機構中的應用日益廣泛、對微流體技術臨床檢測的需求不斷成長、製藥和生物技術領域研發應用的不斷拓展，以及聚合物基微流體材料的日益普及。

預計未來幾年，醫療微流體控裝置市場將快速成長，到2030年將達到127.9億美元，複合年成長率（CAGR）為15.0%。預測期內的成長主要歸功於以下幾個面向：對個人化醫療和晶片器官模型的需求不斷成長；微流體技術在分散式和家庭診斷中的整合應用日益廣泛；微流體平台在感染疾病監測中的應用不斷成長；微流體技術在高通量藥物篩檢中的應用不斷提高微流體裝置在新興醫療市場的滲透率在新興醫療市場的滲透率。預測期內的關鍵趨勢包括：整合晶片實驗室平台的技術進步；基於液滴和紙基的微流體技術的創新；微型生物感測器和檢測器的開發；晶片器官和組織工程系統的研發；以及自動化和人工智慧驅動的微流體分析技術的進步。

預計未來幾年，慢性病盛行率的上升將推動醫療微流體設備市場的成長。慢性病是指長期存在的、通常會隨著時間推移逐漸發展的健康狀況，例如糖尿病、心血管疾病和關節炎，這些疾病往往需要持續的醫療照護和生活方式管理來控制症狀和減少併發症。慢性病發病率的上升主要歸因於不健康的生活方式，例如營養不良、缺乏運動和吸煙，這些都會增加糖尿病、心臟病和肥胖症等疾病的風險。醫療微流體設備能夠精確處理和分析微量體液樣本，從而支援慢性病的管理，實現持續監測和診斷。此外，它們還能透過實現快速檢測、個人化治療方案製定和微創長期疾病監測來改善患者照護。例如，根據英國國家醫療服務體系（NHS）2024年6月的數據，2023年在全科醫生（GP）處註冊的3,615,330人被診斷患有非糖尿病性高血糖或糖尿病前期，比2022年的3,065,825例增加了18%。因此，慢性病盛行率的上升正在推動醫療微流體設備市場的擴張。

主要企業的醫療微流體設備公司正致力於開發先進的解決方案，例如全整合微流體晶片平台，以簡化和加速用於腎臟疾病及其他疾病的生物製藥療法的研發。全整合微流體晶片平台是一種晶片實驗室系統，它將樣品製備、流體處理、反應、分離和檢測等多種實驗室功能整合到單一微型晶片上。例如，2023年6月，美國生命科學分析技術公司AB Sciex LLC發布了Intabio ZT系統，這是首個結合了成像毛細管等電聚焦（icIEF）分離和紫外線檢測的全整合微流體晶片平台。該平台旨在為生物製藥產生全面的電荷異構體數據，並可與ZenoTOF 7600系統無縫整合。此外，它還透過Biologics Explorer軟體提供先進的數據處理功能，透過提供對蛋白質療法的更深入洞察，加速安全有效的生物治療方法的研發。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球醫療微流體控裝置市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 晶片實驗室診斷技術的應用日益廣泛
    • 微流體裝置在即時檢測應用上的廣泛應用
    • 「晶片器官」模型整合進展
    • 高通量微流體平台的擴展
    • 人們對小型診斷系統的興趣日益濃厚

第5章 終端用戶產業市場分析

  • 醫院和診斷診所
  • 診斷與研究機構
  • 製藥和生物技術公司
  • 學術研究機構
  • 居家醫療設施

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球醫療微流體設備市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球醫療微流體控裝置市場規模、對比及成長率分析
  • 全球醫療微流體控裝置市場表現：規模與成長，2020-2025年
  • 全球醫療微流體控裝置市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 依產品類型
  • 晶片實驗室（LOC）系統、微流體晶片和晶片盒、基於液滴的微流體系統、紙基微流體控裝置、連續流微流體系統、器官晶片平台
  • 材料
  • 玻璃、聚合物、矽、金屬、陶瓷
  • 透過使用
  • 即時診斷、藥物發現與開發、晶片器官與組織工程、感染疾病監測
  • 最終用戶
  • 醫院和診斷診所、診斷和研究實驗室、製藥和生物技術公司、學術和研究機構、居家醫療環境
  • 按類型細分：晶片實驗室系統
  • 臨床診斷晶片、環境監測晶片、生化分析晶片、單細胞分析平台
  • 按類型細分：微流體晶片和晶片盒
  • 即時診斷試劑盒、樣本製備吸頭、細胞培養及檢測吸頭、聚合酵素鏈鎖反應(PCR) 吸頭
  • 按類型細分：基於液滴的微流體系統
  • 水包油乳液系統、油包水乳液系統、數位液滴系統、高通量篩檢平台
  • 依類型細分：紙基微流體裝置
  • 橫向流動化驗條、立體紙網路、多重偵測裝置、比色分析條
  • 依類型細分：連續流微流體系統
  • 微反應器系統、細胞分選與分離系統、微混合裝置、化學合成平台
  • 按類型細分：晶片器官平台
  • 晶片肝臟模型、晶片肺模型、晶片心臟模型、多重器官系統模型

第10章 區域與國別分析

  • 全球醫療微流體控裝置市場：依地區分類，實際數據及預測，2020-2025年、2025-2030年、2035年
  • 全球醫療微流體控裝置市場：按國家/地區分類，實際數據和預測數據，2020-2025年、2025-2030年、2035年

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 醫療微流體控裝置市場：競爭格局及市場佔有率（2024年）
  • 醫療微流體控裝置市場：公司估值矩陣
  • 醫療微流體控裝置市場：公司概況
    • Roche Diagnostics
    • Thermo Fisher Scientific Inc
    • Abbott Laboratories
    • Danaher Corporation
    • Agilent Technologies Inc.

第37章 其他大型企業和創新企業

  • Illumina Inc., BioMerieux, PerkinElmer Inc., Bio-Rad Laboratories Inc., Fluidigm Corporation, Spectrum Fluidics, Biosurfit SA, Cellix Ltd., 3M Company, Dolomite Microfluidics, Micronit Microtechnologies BV, Sphere Fluidics Ltd., BioFluidica Inc., uFluidix Inc., Elveflow

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：具有高市場潛力的國家、細分市場與策略

  • 2030年醫療微流體設備市場：提供新機會的國家
  • 2030年醫療微流體設備市場：充滿新機會的細分市場
  • 2030年醫療微流體設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: ME4MMMDI02_G26Q1

Medical microfluidic devices are miniaturized platforms designed to manipulate and control very small volumes of fluids, ranging from microliters to nanoliters, through microchannels for biomedical applications such as diagnostics and analysis. They integrate components including pumps, valves, and sensors onto a single chip, allowing precise handling and processing of samples such as cells, particles, or biofluids, often in lab-on-a-chip configurations. These devices enable functions such as mixing, separation, and detection, supporting advances in point-of-care testing and organ-on-chip models.

The key product types of medical microfluidic devices include lab-on-a-chip systems, microfluidic chips and cartridges, droplet-based systems, paper-based devices, continuous-flow systems, and organ-on-a-chip platforms. Lab-on-a-chip systems integrate multiple lab functions onto a single chip to deliver rapid biological and chemical analysis. Materials include glass, polymers, silicon, metals, and ceramics. Applications include point-of-care diagnostics, drug discovery, tissue engineering, and infectious disease monitoring, used across hospitals, labs, biotech firms, academic institutes, and home-care settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the medical microfluidic devices market by increasing costs of imported polymers, glass substrates, microfabrication equipment, sensors, and control electronics. research laboratories and diagnostic companies in north america and europe are most affected due to reliance on specialized imported components, while asia-pacific faces higher production costs for export-oriented devices. these tariffs are increasing development expenses and slowing commercialization timelines. however, they are also encouraging local fabrication capabilities, regional material sourcing, and innovation in cost-efficient microfluidic manufacturing.

The medical microfluidic devices market research report is one of a series of new reports from The Business Research Company that provides medical microfluidic devices market statistics, including medical microfluidic devices industry global market size, regional shares, competitors with a medical microfluidic devices market share, detailed medical microfluidic devices market segments, market trends and opportunities, and any further data you may need to thrive in the medical microfluidic devices industry. This medical microfluidic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical microfluidic devices market size has grown rapidly in recent years. It will grow from $6.35 billion in 2025 to $7.32 billion in 2026 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to increasing adoption of point-of-care diagnostics, growing use of lab-on-a-chip in research labs, rising demand for microfluidic-based clinical testing, expansion of pharmaceutical and biotech r&d applications and increasing utilization of polymer-based microfluidic materials.

The medical microfluidic devices market size is expected to see rapid growth in the next few years. It will grow to $12.79 billion in 2030 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to growing demand for personalized medicine and organ-on-chip models, increasing integration of microfluidics in decentralized and home diagnostics, rising adoption of microfluidic platforms in infectious disease monitoring, expansion of microfluidic applications in high-throughput drug screening and growing penetration of microfluidic devices in emerging healthcare markets. Major trends in the forecast period include technological advancements in integrated lab-on-a-chip platforms, innovations in droplet-based and paper-based microfluidics, developments in miniaturized biosensors and detectors, research and development in organ-on-chip and tissue engineering systems and technological advancements in automated and ai-enabled microfluidic analysis.

The rising prevalence of chronic diseases is expected to drive the growth of the medical microfluidic devices market in the coming years. Chronic diseases are long-term health conditions that typically progress gradually over time, such as diabetes, cardiovascular diseases, and arthritis, and often require continuous medical care and lifestyle management to control symptoms and reduce complications. The increasing incidence of chronic diseases is largely attributed to unhealthy lifestyle habits, including poor nutrition, lack of physical activity, and smoking, which elevate the risk of conditions such as diabetes, heart disease, and obesity. Medical microfluidic devices support chronic disease management by enabling precise handling and analysis of very small fluid samples for ongoing monitoring and diagnostic purposes. They enhance patient care by facilitating rapid testing, personalized treatment adjustments, and minimally invasive long-term disease monitoring. For example, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, representing an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing prevalence of chronic diseases is contributing to the expansion of the medical microfluidic devices market.

Major companies operating in the medical microfluidic devices market are concentrating on the development of advanced solutions, such as fully integrated microfluidic chip-based platforms, to simplify and accelerate the development of biopharmaceutical therapies used in renal care and other medical conditions. Fully integrated microfluidic chip-based platforms are lab-on-a-chip systems that consolidate multiple laboratory functions-including sample preparation, fluid handling, reactions, separation, and detection-onto a single micro-scale chip. For example, in June 2023, AB Sciex LLC, a US-based life science analytical technology company, introduced the Intabio ZT system, the first fully integrated microfluidic chip-based platform combined with imaged capillary isoelectric focusing (icIEF) separation and UV detection. The platform is designed to generate comprehensive charge isoform data for biopharmaceuticals, featuring seamless integration with the ZenoTOF 7600 system. It also offers advanced data processing through Biologics Explorer software to deliver deeper insights into protein therapeutics, thereby accelerating the development of safe and effective biological treatments.

In July 2023, Unchained Labs Inc., a US-based life sciences tools and research solutions company, acquired Blacktrace Holdings Ltd. for an undisclosed amount. Through this acquisition, Unchained Labs sought to enhance its medical microfluidic devices and lipid nanoparticle (LNP) development offerings by integrating Blacktrace Holdings' Dolomite microfluidics platforms and Particle Works systems, enabling faster, high-throughput formulation screening and scalable production of LNPs used in vaccines, gene therapies, and advanced biologics research. Blacktrace Holdings Ltd. is a UK-based company that develops innovative microfluidic instrumentation and particle formulation technologies to support complex scientific workflows.

Major companies operating in the medical microfluidic devices market are Roche Diagnostics, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Agilent Technologies Inc., Illumina Inc., BioMerieux, PerkinElmer Inc., Bio-Rad Laboratories Inc., Fluidigm Corporation, Spectrum Fluidics, Biosurfit SA, Cellix Ltd., 3M Company, Dolomite Microfluidics, Micronit Microtechnologies B.V., Sphere Fluidics Ltd., BioFluidica Inc., uFluidix Inc., Elveflow, On-chip Biotechnologies, Achira Labs Pvt. Ltd., Akkonni Biosystems Inc.

North America was the largest region in the medical microfluidic devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical microfluidic devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical microfluidic devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical microfluidic devices market consists of sales of lab-on-a-chip devices, microfluidic diagnostic cartridges, microfluidic pumps and valves, biochips for point-of-care testing, microfluidic cell culture platforms, and integrated microfluidic systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Microfluidic Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses medical microfluidic devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical microfluidic devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical microfluidic devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Lab-On-A-Chip (LOC) Systems; Microfluidic Chips And Cartridges; Droplet-Based Microfluidic Systems; Paper-Based Microfluidic Devices; Continuous-Flow Microfluidic Systems; Organ-On-A-Chip Platforms
  • 2) By Material: Glass; Polymer; Silicon; Metals; Ceramics
  • 3) By Application: Point-Of-Care Diagnostics; Drug Discovery And Development; Organ-On-Chip And Tissue Engineering; Infectious Disease Monitoring
  • 4) By End User: Hospitals And Diagnostic Clinics; Diagnostic And Research Laboratories; Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Home Care Settings
  • Subsegments:
  • 1) By Lab-On-A-Chip Systems: Clinical Diagnostic Chips; Environmental Monitoring Chips; Biochemical Analysis Chips; Single-Cell Analysis Platforms
  • 2) By Microfluidic Chips And Cartridges: Point-Of-Care Diagnostic Cartridges; Sample Preparation Chips; Cell Culture And Assay Chips; Polymerase Chain Reaction Chips
  • 3) By Droplet-Based Microfluidic Systems: Water-In-Oil Emulsion Systems; Oil-In-Water Emulsion Systems; Digital Droplet Systems; High-Throughput Screening Platforms
  • 4) By Paper-Based Microfluidic Devices: Lateral Flow Assay Strips; Three-Dimensional Paper Networks; Multiplexed Detection Devices; Colorimetric Analysis Strips
  • 5) By Continuous-Flow Microfluidic Systems: Microreactor Systems; Cell Sorting And Separation Systems; Micromixer Devices; Chemical Synthesis Platforms
  • 6) By Organ-On-A-Chip Platforms: Liver-On-A-Chip Models; Lung-On-A-Chip Models; Heart-On-A-Chip Models; Multi-Organ System Models
  • Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific Inc; Abbott Laboratories; Danaher Corporation; Agilent Technologies Inc.; Illumina Inc.; BioMerieux; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Fluidigm Corporation; Spectrum Fluidics; Biosurfit SA; Cellix Ltd.; 3M Company; Dolomite Microfluidics; Micronit Microtechnologies B.V.; Sphere Fluidics Ltd.; BioFluidica Inc.; uFluidix Inc.; Elveflow; On-chip Biotechnologies; Achira Labs Pvt. Ltd.; Akkonni Biosystems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Medical Microfluidic Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Medical Microfluidic Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Medical Microfluidic Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Medical Microfluidic Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Lab-On-A-Chip Diagnostics
    • 4.2.2 Rising Use Of Point-Of-Care Microfluidic Devices
    • 4.2.3 Growing Integration Of Organ-On-Chip Models
    • 4.2.4 Expansion Of High-Throughput Microfluidic Platforms
    • 4.2.5 Enhanced Focus On Miniaturized Diagnostic Systems

5. Medical Microfluidic Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals And Diagnostic Clinics
  • 5.2 Diagnostic And Research Laboratories
  • 5.3 Pharmaceutical And Biotechnology Companies
  • 5.4 Academic And Research Institutes
  • 5.5 Home Care Settings

6. Medical Microfluidic Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Medical Microfluidic Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Medical Microfluidic Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Medical Microfluidic Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Medical Microfluidic Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Medical Microfluidic Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Medical Microfluidic Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Medical Microfluidic Devices Market Segmentation

  • 9.1. Global Medical Microfluidic Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lab-On-A-Chip (LOC) Systems, Microfluidic Chips And Cartridges, Droplet-Based Microfluidic Systems, Paper-Based Microfluidic Devices, Continuous-Flow Microfluidic Systems, Organ-On-A-Chip Platforms
  • 9.2. Global Medical Microfluidic Devices Market, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Glass, Polymer, Silicon, Metals, Ceramics
  • 9.3. Global Medical Microfluidic Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Point-Of-Care Diagnostics, Drug Discovery And Development, Organ-On-Chip And Tissue Engineering, Infectious Disease Monitoring
  • 9.4. Global Medical Microfluidic Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Diagnostic Clinics, Diagnostic And Research Laboratories, Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Home Care Settings
  • 9.5. Global Medical Microfluidic Devices Market, Sub-Segmentation Of Lab-On-A-Chip Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Diagnostic Chips, Environmental Monitoring Chips, Biochemical Analysis Chips, Single-Cell Analysis Platforms
  • 9.6. Global Medical Microfluidic Devices Market, Sub-Segmentation Of Microfluidic Chips And Cartridges, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Point-Of-Care Diagnostic Cartridges, Sample Preparation Chips, Cell Culture And Assay Chips, Polymerase Chain Reaction Chips
  • 9.7. Global Medical Microfluidic Devices Market, Sub-Segmentation Of Droplet-Based Microfluidic Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Water-In-Oil Emulsion Systems, Oil-In-Water Emulsion Systems, Digital Droplet Systems, High-Throughput Screening Platforms
  • 9.8. Global Medical Microfluidic Devices Market, Sub-Segmentation Of Paper-Based Microfluidic Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lateral Flow Assay Strips, Three-Dimensional Paper Networks, Multiplexed Detection Devices, Colorimetric Analysis Strips
  • 9.9. Global Medical Microfluidic Devices Market, Sub-Segmentation Of Continuous-Flow Microfluidic Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microreactor Systems, Cell Sorting And Separation Systems, Micromixer Devices, Chemical Synthesis Platforms
  • 9.10. Global Medical Microfluidic Devices Market, Sub-Segmentation Of Organ-On-A-Chip Platforms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Liver-On-A-Chip Models, Lung-On-A-Chip Models, Heart-On-A-Chip Models, Multi-Organ System Models

10. Medical Microfluidic Devices Market Regional And Country Analysis

  • 10.1. Global Medical Microfluidic Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Medical Microfluidic Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Medical Microfluidic Devices Market

  • 11.1. Asia-Pacific Medical Microfluidic Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Medical Microfluidic Devices Market

  • 12.1. China Medical Microfluidic Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Medical Microfluidic Devices Market

  • 13.1. India Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Medical Microfluidic Devices Market

  • 14.1. Japan Medical Microfluidic Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Medical Microfluidic Devices Market

  • 15.1. Australia Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Medical Microfluidic Devices Market

  • 16.1. Indonesia Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Medical Microfluidic Devices Market

  • 17.1. South Korea Medical Microfluidic Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Medical Microfluidic Devices Market

  • 18.1. Taiwan Medical Microfluidic Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Medical Microfluidic Devices Market

  • 19.1. South East Asia Medical Microfluidic Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Medical Microfluidic Devices Market

  • 20.1. Western Europe Medical Microfluidic Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Medical Microfluidic Devices Market

  • 21.1. UK Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Medical Microfluidic Devices Market

  • 22.1. Germany Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Medical Microfluidic Devices Market

  • 23.1. France Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Medical Microfluidic Devices Market

  • 24.1. Italy Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Medical Microfluidic Devices Market

  • 25.1. Spain Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Medical Microfluidic Devices Market

  • 26.1. Eastern Europe Medical Microfluidic Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Medical Microfluidic Devices Market

  • 27.1. Russia Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Medical Microfluidic Devices Market

  • 28.1. North America Medical Microfluidic Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Medical Microfluidic Devices Market

  • 29.1. USA Medical Microfluidic Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Medical Microfluidic Devices Market

  • 30.1. Canada Medical Microfluidic Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Medical Microfluidic Devices Market

  • 31.1. South America Medical Microfluidic Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Medical Microfluidic Devices Market

  • 32.1. Brazil Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Medical Microfluidic Devices Market

  • 33.1. Middle East Medical Microfluidic Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Medical Microfluidic Devices Market

  • 34.1. Africa Medical Microfluidic Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Medical Microfluidic Devices Market, Segmentation By Product Type, Segmentation By Material, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Medical Microfluidic Devices Market Regulatory and Investment Landscape

36. Medical Microfluidic Devices Market Competitive Landscape And Company Profiles

  • 36.1. Medical Microfluidic Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Medical Microfluidic Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Medical Microfluidic Devices Market Company Profiles
    • 36.3.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Medical Microfluidic Devices Market Other Major And Innovative Companies

  • Illumina Inc., BioMerieux, PerkinElmer Inc., Bio-Rad Laboratories Inc., Fluidigm Corporation, Spectrum Fluidics, Biosurfit SA, Cellix Ltd., 3M Company, Dolomite Microfluidics, Micronit Microtechnologies B.V., Sphere Fluidics Ltd., BioFluidica Inc., uFluidix Inc., Elveflow

38. Global Medical Microfluidic Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Medical Microfluidic Devices Market

40. Medical Microfluidic Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Medical Microfluidic Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Medical Microfluidic Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Medical Microfluidic Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer